المؤلفون: N Hamajima, K Hirose, K Tajima, T Rohan, CM Friedenreich, SM Gapstur, MM Gaudet, RJ Coates, JM Liff, E Kakouri, Y Marcou, SW Duffy, A Morabia, L Schuman, W Stewart, M Szklo, P Band, AJ Coldman, RP Gallagher, TG Hislop, P Yang, SR Cummings, J Hu, KC Johnson, Y Mao, P Chao, J Lissowska, K Canfell, PL Horn-Ross, LM Kolonel, AMY Nomura, T Bishop, D Palli, S De Sanjose, CA Gonzalez, N Lee, P Marchbanks, HW Ory, HB Peterson, P Wingo, K Ebeling, D Kunde, P Nishan, L Bergkvist, JL Hopper, F Sitas, S Franceschi, L Dal Maso, TH Chan, AH Eliassen, RM Tamimi, WC Willett, V Gajalakshmi, N Martin, T Pardthaisong, S Silpisornkosol, C Theetranont, B Boosiri, S Chutivongse, P Jimakorn, P Virutamasen, C Wongsrichanalai, A Neugut, R Santella, A Hadjisavvas, K Kyriacou, M Loizidou, CJ Baines, N Kreiger, AB Miller, C Wall, A Tjonneland T Jorgensen, C Stahlberg, A T0nnes Pedersen, E Negri, SE Hankinson, D Flesch-Janys, C La Vecchia, N Hakansson, I Heuch, HO Adami, E Weiderpass, A Ekbom, G Erlandsson, I Persson, C Magnusson, L Jones, K McPherson, A Neil, M Vessey, D Yeates, G Berry, J Cooper Booth, T Jelihovsky, R MacLennan, J Chang-Claude, R Kaaks, M Iwasaki, S Tsugane, GL Anderson, JR Daling, WB Hutchinson, CI Li, KE Malone, M Mandelson, PA Newcomb, EA Noonan, RM Ray, JL Stanford, MTC Tang, DB Thomas, NS Weiss, E White, A Izquierdo, P Viladiu, KM Egan, HR Cuevas, P Ontiveros, A Palet, SB Salazar, N Aristizabal, A Cuadros, L Tryggvadottir, EJ Olafsdottir, E Riboli, N Andrieu, A Bachelot, A Bremond, B Gairard, J Lansac, MG Le, L Piana, R Renaud, MC Boutron-Ruault, N Chabbert-Buffet, F Clavel-Chapelon, A Fournier, S Mesrine, F Levi, M Jones, AJ Swerdlow, A Wolk, K Kosmelj, M Primic-Zakelj, J Stare, G Torres-Mejia, I Romieu, P Boyle, F Lubin, B Modan, E Ron, Y Wax, M Ferraroni, E Marubini, EM Monninkhof, NC Onland-Moret, PHM Peeters, GD Friedman, RA Hiatt, M Touillaud, WL Beeson, G Fraser, J Peto, RL Hanson, MC Leske, MC Mahoney, PC Nasca, AO Varma, AL Weinstein, RA Goldbohm, PA van den Brandt, N Chantarakul, S Koetsawang, D Rachawat, MC Pike, M Gerber, S Richardson, C Segala, S Teitelbaum, D Gatei, P Kenya, A Kungu, JG Mati, LA Brinton, M Freedman, R Hoover, C Schairer, RG Ziegler, E Banks, R Spirtas, HP Lee, MA Rookus, FE van Leeuwen, JA Schoenberg, S Graff-Iversen, R Selmer, S Atkinson, I Barnes, V Beral, D Bull, T Gathani, A Goodill, J Green, C Hermon, T Key, K Pirie, G Reeves, K Shaw, TO Yang, R Collins, HC Pan, R Peto, R Ghiasvand, K Mabuchi, D Preston, SE McCann, P Hannaford, C Kay, JM Hampton, LJ Titus, A Trentham-Dietz, B Liu, YT Gao, F Jin, J-M Yuan, HY Wei, T Yun, C Zhiheng, PF Coogan, JR Palmer, L Rosenberg, EM John, Q-S Wang, M Kawai, Y Minami, I Tsuji, M Kumle, H Stalsberg, E Lund, EO Fourkala, I Jacobs, U Menon, A Ryan, L Hartman, H Olsson, K Katsouyanni, A Trichopoulou, A Tzonou, KA Baltzell, A Dabancens, L Martinez, R Molina, O Salas, L Rosero-Bixby, FE Alexander, K Anderson, AR Folsom, MD Gammon, BS Hulka, R Millikan, CED Chilvers, M McCredie, C Paul, DCG Skegg, GFS Spears, F Lumachi, TR Rebbeck, RA Apelo, J Baens, JR de la Cruz, B Javier, LB Lacaya, CA Ngelangel, J Cauley, for the Study of Osteoporotic Fractures, C Bain, F Schofield, V Siskind, L Bernstein, S Enger, RW Haile, A Paganini-Hill, G Ursin, AH Wu, MC Yu, M Ewertz, EA Clarke, XO Shu, W Zheng, M Gass, MJ O’Sullivan, A Kalache, TMM Farley, S Holck, O Meirik, A Fukao, X Zhou

المساهمون: RS: GROW - R1 - Prevention, RS: CAPHRI - R5 - Optimising Patient Care, Epidemiologie, N Hamajima, K Hirose, K Tajima, T Rohan, CM Friedenreich, SM Gapstur, MM Gaudet, RJ Coate, JM Liff, E Kakouri, Y Marcou, SW Duffy, A Morabia, L Schuman, W Stewart, M Szklo, P Band, AJ Coldman, RP Gallagher, TG Hislop, P Yang, SR Cumming, J Hu, KC Johnson, Y Mao, P Chao, J Lissowska, K Canfell, PL Horn-Ro, LM Kolonel, AMY Nomura, T Bishop, D Palli, S De Sanjose, CA Gonzalez, N Lee, P Marchbank, HW Ory, HB Peterson, P Wingo, K Ebeling, D Kunde, P Nishan, L Bergkvist, JL Hopper, F Sita, S Franceschi, L Dal Maso, TH Chan, AH Eliassen, RM Tamimi, WC Willett, V Gajalakshmi, N Martin, T Pardthaisong, S Silpisornkosol, C Theetranont, B Boosiri, S Chutivongse, P Jimakorn, P Virutamasen, C Wongsrichanalai, A Neugut, R Santella, A Hadjisavva, K Kyriacou, M Loizidou, CJ Baine, N Kreiger, AB Miller, C Wall, A Tjonneland T Jorgensen, C Stahlberg, A T0nnes Pedersen, E Negri, SE Hankinson, D Flesch-Jany, C La Vecchia, N Hakansson, I Heuch, HO Adami, E Weiderpa, A Ekbom, G Erlandsson, I Persson, C Magnusson, L Jone, K McPherson, A Neil, M Vessey, D Yeate, G Berry, J Cooper Booth, T Jelihovsky, R MacLennan, J Chang-Claude, R Kaak, M Iwasaki, S Tsugane, GL Anderson, JR Daling, WB Hutchinson, CI Li, KE Malone, M Mandelson, PA Newcomb, EA Noonan, RM Ray, JL Stanford, MTC Tang, DB Thoma, NS Wei, E White, A Izquierdo, P Viladiu, KM Egan, HR Cueva, P Ontivero, A Palet, SB Salazar, N Aristizabal, A Cuadro, L Tryggvadottir, EJ Olafsdottir, E Riboli, N Andrieu, A Bachelot, A Bremond, B Gairard, J Lansac, MG Le, L Piana, R Renaud, MC Boutron-Ruault, N Chabbert-Buffet, F Clavel-Chapelon, A Fournier, S Mesrine, F Levi, M Jone, AJ Swerdlow, A Wolk, K Kosmelj, M Primic-Zakelj, J Stare, G Torres-Mejia, I Romieu, P Boyle, F Lubin, B Modan, E Ron, Y Wax, M Ferraroni, E Marubini, EM Monninkhof, NC Onland-Moret, PHM Peeter, GD Friedman, RA Hiatt, M Touillaud, WL Beeson, G Fraser, J Peto, RL Hanson, MC Leske, MC Mahoney, PC Nasca, AO Varma, AL Weinstein, RA Goldbohm, PA van den Brandt, N Chantarakul, S Koetsawang, D Rachawat, MC Pike, M Gerber, S Richardson, C Segala, S Teitelbaum, D Gatei, P Kenya, A Kungu, JG Mati, LA Brinton, M Freedman, R Hoover, C Schairer, RG Ziegler, E Bank, R Spirta, HP Lee, MA Rooku, FE van Leeuwen, JA Schoenberg, S Graff-Iversen, R Selmer, S Atkinson, I Barne, V Beral, D Bull, T Gathani, A Goodill, J Green, C Hermon, T Key, K Pirie, G Reeve, K Shaw, TO Yang, R Collin, HC Pan, R Peto, R Ghiasvand, K Mabuchi, D Preston, SE McCann, P Hannaford, C Kay, JM Hampton, LJ Titu, A Trentham-Dietz, B Liu, YT Gao, F Jin, J-M Yuan, HY Wei, T Yun, C Zhiheng, PF Coogan, JR Palmer, L Rosenberg, EM John, Q-S Wang, M Kawai, Y Minami, I Tsuji, M Kumle, H Stalsberg, E Lund, EO Fourkala, I Jacob, U Menon, A Ryan, L Hartman, H Olsson, K Katsouyanni, A Trichopoulou, A Tzonou, KA Baltzell, A Dabancen, L Martinez, R Molina, O Sala, L Rosero-Bixby, FE Alexander, K Anderson, AR Folsom, MD Gammon, BS Hulka, R Millikan, CED Chilver, M McCredie, C Paul, DCG Skegg, GFS Spear, F Lumachi, TR Rebbeck, RA Apelo, J Baen, JR de la Cruz, B Javier, LB Lacaya, CA Ngelangel, J Cauley, for the Study of Osteoporotic Fracture, C Bain, F Schofield, V Siskind, L Bernstein, S Enger, RW Haile, A Paganini-Hill, G Ursin, AH Wu, MC Yu, M Ewertz, EA Clarke, XO Shu, W Zheng, M Ga, MJ O’Sullivan, A Kalache, TMM Farley, S Holck, O Meirik, A Fukao, X Zhou, Pirie, K, Cancer, Collaborative Group on Hormonal Factors in Breast

المصدر: Lancet, 394(10204), 1159-1168. Elsevier Science

مصطلحات موضوعية: Adult, Risk, Oncology, medicine.medical_specialty, Time Factors, menopause, Breast Neoplasms, 030204 cardiovascular system & hematology, meta-analysi, 03 medical and health sciences, breast cancer, 0302 clinical medicine, Breast cancer, ESTROGEN-PLUS-PROGESTIN, Risk Factors, Internal medicine, Epidemiology of cancer, Epidemiology, medicine, Humans, Obesity, 030212 general & internal medicine, Progesterone, Aged, Principal Component Analysis, INITIATIVE CLINICAL-TRIAL, hormone therapy, business.industry, Estrogen Replacement Therapy, Estrogens, General Medicine, Middle Aged, medicine.disease, 3. Good health, Logistic Models, POSTMENOPAUSAL WOMEN, Meta-analysis, epidemiology, Drug Therapy, Combination, Female, Menopausal hormone therapy, Progestins, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::439d0f8027a6f9d2226fb0e42b5966f1
https://cris.maastrichtuniversity.nl/en/publications/88a75911-ca7a-43e6-91a1-ba6c24758e34

المؤلفون: Tin Tin S; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Smith-Byrne K; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Ferrari P; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France., Rinaldi S; International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France., McCullough ML; Department of Population Science, American Cancer Society, Atlanta, Georgia, USA., Teras LR; Department of Population Science, American Cancer Society, Atlanta, Georgia, USA., Manjer J; Department of Surgery, Skåne University Hospital Malmö, Lund University, Malmö, Sweden., Giles G; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia., Le Marchand L; University of Hawai'i Cancer Center, University of Hawai'i, Honolulu, Hawaii, USA., Haiman CA; USC Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA., Wilkens LR; University of Hawai'i Cancer Center, University of Hawai'i, Honolulu, Hawaii, USA., Chen Y; Division of Epidemiology, Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA., Hankinson S; Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts, USA., Tworoger S; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA., Eliassen AH; Departments of Nutrition & Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Willett WC; Departments of Nutrition & Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Ziegler RG; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Fuhrman BJ; Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Sieri S; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Agnoli C; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Cauley J; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Menon U; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Fourkala EO; EGA Institute for Women's Health, University College London, London, UK., Rohan TE; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA., Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center, DKFZ, Heidelberg, Germany., Reeves GK; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Key TJ; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

المصدر: Cancer [Cancer] 2024 Oct 01; Vol. 130 (19), pp. 3375-3386. Date of Electronic Publication: 2024 Jun 02.

نوع المنشور: Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Mendelian Randomization Analysis* , Alcohol Drinking* , Gonadal Steroid Hormones*/blood , Sex Hormone-Binding Globulin*/metabolism , Sex Hormone-Binding Globulin*/analysis , Premenopause*/blood, Humans ; Female ; Cohort Studies ; Breast Neoplasms/genetics ; Breast Neoplasms/blood ; Postmenopause/blood ; Middle Aged ; Alcohol Dehydrogenase/genetics ; Cross-Sectional Studies ; Progesterone/blood ; Testosterone/blood ; Adult ; Estradiol/blood

المؤلفون: Tin ST; University of Oxford., Smith-Byrne K; University of Oxford., Ferrari P; International Agency for Research on Cancer (IARC/WHO)., Rinaldi S; International Agency for Research on Cancer (IARC/WHO)., McCullough ML; American Cancer Society., Teras LR; American Cancer Society., Manjer J; Skåne University Hospital Malmö, Lund University., Giles G; Cancer Council Victoria., Marchand LL; University of Hawai'i Cancer Center, University of Hawai'i., Haiman CA; University of Southern California., Wilkens LR; University of Hawai'i Cancer Center, University of Hawai'i., Chen Y; New York University Grossman School of Medicine., Hankinson S; University of Massachusetts., Tworoger S; Moffitt Cancer Center., Eliassen AH; Harvard T.H. Chan School of Public Health., Willett WC; Harvard T.H. Chan School of Public Health., Ziegler RG; National Cancer Institute., Fuhrman BJ; University of Pittsburgh., Sieri S; Fondazione IRCCS Istituto Nazionale dei Tumori., Agnoli C; Fondazione IRCCS Istituto Nazionale dei Tumori., Cauley J; University of Pittsburgh., Menon U; University College London., Fourkala EO; University College London., Rohan TE; Albert Einstein College of Medicine., Kaaks R; German Cancer Research Center, DKFZ., Reeves GK; University of Oxford., Key TJ; University of Oxford.

المصدر: Research square [Res Sq] 2023 Aug 16. Date of Electronic Publication: 2023 Aug 16.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet ISSN: 2693-5015 (Electronic) Linking ISSN: 26935015 NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE

المؤلفون: Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK. u.menon@ucl.ac.uk., Weller D; Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK., Falborg AZ; Research Unit for General Practice, Aarhus, Denmark., Jensen H; Research Unit for General Practice, Aarhus, Denmark., Butler J; The Royal Marsden NHS Foundation Trust, London, UK., Barisic A; Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada., Knudsen AK; European Palliative Care Research Centre (PRC), Department of Oncology, Oslo, Norway.; University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Bergin RJ; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Department of General Practice, University of Melbourne, Melbourne, VIC, Australia., Brewster DH; Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.; Scottish Cancer Registry, Edinburgh, UK., Cairnduff V; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK., Fourkala EO; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK., Gavin AT; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK., Grunfeld E; Health Services Research Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Harland E; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Canada., Kalsi J; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK., Law RJ; North Wales Centre for Primary Care Research, Bangor University, Wrexham, UK., Lin Y; European Palliative Care Research Centre (PRC), Department of Oncology, Oslo, Norway., Turner D; Population Oncology, Cancer Care Manitoba, Winnipeg, Canada., Neal RD; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK., White V; School of Psychology Deakin University, Geelong, VIC, Australia.; Centre for Behavioral Research in Cancer, Cancer Council Victoria, Melbourne, VIC, Australia., Harrison S; International Cancer Benchmarking Partnership, Cancer Research UK, Stratford, UK., Reguilon I; International Cancer Benchmarking Partnership, Cancer Research UK, Stratford, UK., Lynch C; International Cancer Benchmarking Partnership, Cancer Research UK, Stratford, UK., Vedsted P; International Cancer Benchmarking Partnership, Cancer Research UK, Stratford, UK.

مؤلفون مشاركون: ICBP Module 4 Working Group

المصدر: British journal of cancer [Br J Cancer] 2022 Sep; Vol. 127 (5), pp. 844-854. Date of Electronic Publication: 2022 May 26.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Benchmarking* , Ovarian Neoplasms*/diagnosis , Ovarian Neoplasms*/therapy, Carcinoma, Ovarian Epithelial ; Female ; Humans ; Primary Health Care ; Referral and Consultation

المؤلفون: Simmons AR; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas., Fourkala EO; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom., Gentry-Maharaj A; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom., Ryan A; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom., Sutton MN; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas., Baggerly K; Department of Bioinformatics, University of Texas MD Anderson Cancer Center, Houston, Texas., Zheng H; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas., Jacobs I; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom., Skates S; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts., Menon U; Department of Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, London, United Kingdom., Bast RC Jr; Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas. rbast@mdanderson.org.

المصدر: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2019 Jun; Vol. 12 (6), pp. 391-400. Date of Electronic Publication: 2019 Apr 09.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1940-6215 (Electronic) Linking ISSN: 19406215 NLM ISO Abbreviation: Cancer Prev Res (Phila) Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma, Clear Cell/*diagnosis , Adenocarcinoma, Mucinous/*diagnosis , Biomarkers, Tumor/*blood , CA-125 Antigen/*blood , Cystadenocarcinoma, Serous/*diagnosis , Endometrial Neoplasms/*diagnosis , Ovarian Neoplasms/*diagnosis, Adenocarcinoma, Clear Cell/blood ; Adenocarcinoma, Mucinous/blood ; Aged ; Algorithms ; Case-Control Studies ; Cystadenocarcinoma, Serous/blood ; Early Detection of Cancer/methods ; Endometrial Neoplasms/blood ; Female ; Follow-Up Studies ; Humans ; Longitudinal Studies ; Middle Aged ; Ovarian Neoplasms/blood ; Prognosis ; Retrospective Studies

المؤلفون: Thomas DS; Women's Cancer, Institute for Women's Health, University College London, London WC1E 6BT, UK., Gentry-Maharaj A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London WC1V 6LJ, UK., Ryan A; Women's Cancer, Institute for Women's Health, University College London, London WC1E 6BT, UK; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London WC1V 6LJ, UK., Fourkala EO; Women's Cancer, Institute for Women's Health, University College London, London WC1E 6BT, UK., Apostolidou S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London WC1V 6LJ, UK., Burnell M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London WC1V 6LJ, UK., Alderton W; Abcodia Ltd., UK., Barnes J; Abcodia Ltd., UK., Timms JF; Women's Cancer, Institute for Women's Health, University College London, London WC1E 6BT, UK., Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London WC1V 6LJ, UK. Electronic address: u.menon@ucl.ac.uk.

المصدر: Cancer epidemiology [Cancer Epidemiol] 2019 Feb; Vol. 58, pp. 167-174. Date of Electronic Publication: 2019 Jan 04.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101508793 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1877-783X (Electronic) Linking ISSN: 18777821 NLM ISO Abbreviation: Cancer Epidemiol Subsets: MEDLINE

مواضيع طبية MeSH: Self Report*, Colorectal Neoplasms/*diagnosis , Early Detection of Cancer/*statistics & numerical data , Hospitalization/*statistics & numerical data , Ovarian Neoplasms/*diagnosis , Registries/*statistics & numerical data, Aged ; Aged, 80 and over ; Colorectal Neoplasms/complications ; Colorectal Neoplasms/epidemiology ; Female ; Humans ; Middle Aged ; Ovarian Neoplasms/complications ; Ovarian Neoplasms/epidemiology ; Prognosis ; ROC Curve ; Retrospective Studies ; United Kingdom/epidemiology

المؤلفون: Yang WL; University of Texas MD Anderson Cancer Center, Houston, Texas.; Odyssey Program, University of Texas MD Anderson Cancer Center, Houston, Texas., Gentry-Maharaj A; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, United Kingdom., Simmons A; University of Texas MD Anderson Cancer Center, Houston, Texas., Ryan A; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, United Kingdom., Fourkala EO; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, United Kingdom., Lu Z; University of Texas MD Anderson Cancer Center, Houston, Texas., Baggerly KA; University of Texas MD Anderson Cancer Center, Houston, Texas., Zhao Y; University of Texas MD Anderson Cancer Center, Houston, Texas., Lu KH; University of Texas MD Anderson Cancer Center, Houston, Texas., Bowtell D, Jacobs I; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, United Kingdom.; University of New South Wales, Australia.; University of Manchester, United Kingdom., Skates SJ; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., He WW; OriGene Technologies, Inc., Rockville, Maryland., Menon U; Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, University College London, United Kingdom., Bast RC Jr; University of Texas MD Anderson Cancer Center, Houston, Texas. rbast@mdanderson.org.

مؤلفون مشاركون: AOCS Study Group

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Oct 01; Vol. 23 (19), pp. 5912-5922. Date of Electronic Publication: 2017 Jun 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*blood , CA-125 Antigen/*blood , Membrane Proteins/*blood , Neoplasms, Glandular and Epithelial/*blood , Ovarian Neoplasms/*blood , Tumor Suppressor Protein p53/*blood, Adult ; Aged ; Australia ; Autoantibodies/blood ; Carcinoma, Ovarian Epithelial ; Early Detection of Cancer ; Female ; Humans ; Middle Aged ; Neoplasms, Glandular and Epithelial/immunology ; Neoplasms, Glandular and Epithelial/pathology ; Ovarian Neoplasms/immunology ; Ovarian Neoplasms/pathology ; Tumor Suppressor Protein p53/immunology ; United Kingdom ; United States

المؤلفون: Kiechl S; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Schramek D; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.; The Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada., Widschwendter M; Department of Women's Cancer, EGA Institute of Women's Health, University College London, London, United Kingdom., Fourkala EO; Department of Women's Cancer, EGA Institute of Women's Health, University College London, London, United Kingdom., Zaikin A; Department of Women's Cancer, EGA Institute of Women's Health, University College London, London, United Kingdom.; Department of Mathematics, University College London, London, United Kingdom., Jones A; Department of Mathematics, University College London, London, United Kingdom., Jaeger B; Department of Women's Cancer, EGA Institute of Women's Health, University College London, London, United Kingdom., Rack B; Department of Women's Cancer, EGA Institute of Women's Health, University College London, London, United Kingdom., Janni W; Department of Gynecology and Obstetrics, University Duesseldorf, Duesseldorf, Germany., Scholz C; Heinrich-Heine-University Dusseldorf, Dusseldorf, Germany., Willeit J; Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Weger S; Department of Internal Medicine, Bruneck Hospital, Bruneck, Italy., Mayr A; Department of Internal Medicine, Bruneck Hospital, Bruneck, Italy., Teschendorff A; Statistical Genomics Group, Paul O'Gorman Building, UCL Cancer Institute, University College London, London, United Kingdom., Rosenthal A; Barts Cancer Institute CR UK Centre of Excellence, Queen Mary University of London, Charterhouse Square, London, United Kingdom., Fraser L; Department of Mathematics, University College London, London, United Kingdom., Philpott S; Department of Mathematics, University College London, London, United Kingdom., Dubeau L; Department of Pathology, USC/Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Keshtgar M; Department of Surgery, Royal Free and University College London Medical School, London, United Kingdom., Roylance R; Barts Cancer Institute CR UK Centre of Excellence, Queen Mary University of London, Charterhouse Square, London, United Kingdom., Jacobs IJ; Department of Women's Cancer, EGA Institute of Women's Health, University College London, London, United Kingdom.; UNSW Australia, Sydney, New South Wales, Australia., Menon U; Department of Women's Cancer, EGA Institute of Women's Health, University College London, London, United Kingdom., Schett G; Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany., Penninger JM; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.

المصدر: Oncotarget [Oncotarget] 2017 Jan 17; Vol. 8 (3), pp. 3811-3825.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*metabolism , Neoplastic Cells, Circulating/*metabolism , Osteoprotegerin/*blood , Progesterone/*blood , RANK Ligand/*blood, Biomarkers, Tumor/blood ; Breast Neoplasms/blood ; Early Detection of Cancer ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Postmenopause ; Prospective Studies ; Receptor Activator of Nuclear Factor-kappa B/blood ; Up-Regulation

المؤلفون: Russell MR; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., D'Amato A; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Graham C; School of Healthcare Science, Manchester Metropolitan University, UK., Crosbie EJ; Gynaecological Oncology Research Group, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Gentry-Maharaj A; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK., Ryan A; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK., Kalsi JK; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK., Fourkala EO; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK., Dive C; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK., Walker M; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Whetton AD; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Menon U; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK., Jacobs I; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.; University of New South Wales, Australia., Graham RL; Stoller Biomarker Discovery Centre and Pathology Node, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

المصدر: Oncotarget [Oncotarget] 2017 Jan 03; Vol. 8 (1), pp. 785-797.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Models, Statistical*, Ovarian Neoplasms/*epidemiology, Algorithms ; Biomarkers, Tumor ; Early Detection of Cancer/methods ; Epidemiologic Factors ; Female ; Humans ; Mass Screening ; Neoplasm Staging ; Ovarian Neoplasms/diagnosis ; ROC Curve ; Reproducibility of Results ; Risk

المؤلفون: Fourkala EO; Women's Cancer, Institute for Women's Health, University College London, London, UK., Blyuss O; Women's Cancer, Institute for Women's Health, University College London, London, UK., Field H; Specialist Laboratory Medicine, St James's University Hospital, Leeds, UK. Electronic address: Helen.Field@nhs.net., Gunu R; Women's Cancer, Institute for Women's Health, University College London, London, UK., Ryan A; Women's Cancer, Institute for Women's Health, University College London, London, UK., Barth J; Specialist Laboratory Medicine, St James's University Hospital, Leeds, UK. Electronic address: Julian.Barth@nhs.net., Jacobs I; University of New South Wales, Sydney, NSW 2052, Australia., Zaikin A; Department of Mathematics, University College London, London, UK; Women's Cancer, Institute for Women's Health, University College London, London, UK. Electronic address: alexey.zaikin@ucl.ac.uk., Dawnay A; Department of Clinical Biochemistry, University College London Hospitals NHS Foundation Trust, London, UK., Menon U; Women's Cancer, Institute for Women's Health, University College London, London, UK. Electronic address: u.menon@ucl.ac.uk.

المصدر: Steroids [Steroids] 2016 Sep; Vol. 113, pp. 113.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0404536 Publication Model: Print Cited Medium: Internet ISSN: 1878-5867 (Electronic) Linking ISSN: 0039128X NLM ISO Abbreviation: Steroids Subsets: PubMed not MEDLINE